FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine. Method for prevention and/or treatment of viral infections, involving administering the composition. Disclosed is a composition of high-purity extract yeast RNA having weight not less than 75 % of fragments 25±10 nucleotides, with purity preferably at least 99 %, in combination with mannitol in the ratio of 2:1 to 3:1, where the extract yeast RNA is preliminarily heated mannitol, the extract of yeast RNA is not less than 50 % of composition weight. Disclosed is a method of preparing said composition.
EFFECT: presented group of inventions provides the new antiviral agent with prolonged action.
28 cl, 15 dwg, 14 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION BASED ON HERBAL EXTRACTS FOR TREATMENT AND PREVENTION OF VIRAL INFECTIONS AND SYPHILIS AND METHOD OF TREATMENT AND PREVENTION OF VIRAL INFECTIONS AND SYPHILIS | 2009 |
|
RU2401121C1 |
ANTIVIRAL AGENT BASED ON DRY EXTRACT OF FRUIT BODY OF XYLOTROPHIC BASIDIOMYCETES Bjerkandera adusta | 2015 |
|
RU2580296C1 |
PEGYLATED INTERFERON LAMBDA WITH HIGH BIOACCESSABILITY IN ORAL USE AND METHOD FOR PRODUCTION THEREOF | 2017 |
|
RU2678332C1 |
ANTIVIRAL AGENT BASED ON HUMIC ACIDS | 2018 |
|
RU2678986C1 |
AGENT FOR INHIBITION OF REPRODUCTION OF ENVELOPED VIRUSES, METHOD FOR ITS PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF VIRAL INFECTIONS | 2003 |
|
RU2236852C1 |
METHOD FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH LOW DENSITY OF INTERFERON RECEPTORS | 2013 |
|
RU2595862C2 |
ANTIVIRAL AGENT | 2014 |
|
RU2564919C1 |
AGENT FOR VIRUS DISEASES PREVENTION AND TREATMENT AND METHOD OF VIRUS DISEASES PREVENTION AND TREATMENT | 2007 |
|
RU2337703C1 |
ANTIVIRAL ACTIVITY OF FULLERENE AQUEOUS SOLUTION | 2018 |
|
RU2694754C1 |
PREPARATION "MILON" FOR PROPHYLAXIS AND TREATMENT OF SICK MAMMALS | 1998 |
|
RU2135206C1 |
Authors
Dates
2016-09-10—Published
2012-03-02—Filed